The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused ...

Brad Miller, Moderna's CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue ...

Yes, you can get your flu and COVID-19 shots at the same time. Don't call them boosters — they're not just another dose of ...

While Moderna announced positive Phase 3 data in June 2024, BioNTech and Pfizer released an update on their Phase 3 trial in ...

Novavax cut its annual revenue forecast on Tuesday, citing lower-than-expected sales of its COVID-19 vaccine, ahead of ...

Australia’s audit office will probe the Morrison government’s $2 billion deal with US pharmaceutical giant Moderna to set up ...

The number of COVID cases increased last week to 146. Cases had been falling in April and May and were as low as 31 at the ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

Lisa Domski, 66, who worked at health insurance company Blue Cross Blue Shield of Michigan for more than 30 years, said she ...

With a market cap of $18 billion, Moderna is at the forefront of innovative healthcare solutions, pioneering treatments for ...

H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on Novavax (NVAX – Research Report) today and set a price target of ...